Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Vaccine|August 20, 2021
Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovationsMercy Mvundura, Collrane Frivold, Anna Janik Osborne, et al.
Pathogens (Basel, Switzerland)|May 27, 2023
Assessing the Operational Feasibility of Integrating Point-of-Care G6PD Testing into Plasmodium vivax Malaria Management in VietnamEmily Gerth-Guyette, Huyen Thanh Nguyen, Spike Nowak, et al.
Vaccine|April 14, 2015
Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and TanzaniaMercy Mvundura, Kristina Lorenson, Amos Chweya, et al.
Vaccine|March 17, 2015
An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccineBruce Y Lee, Sarah M Bartsch, Mercy Mvundura, et al.
PLOS Global Public Health|March 24, 2023
Cost of wastewater-based environmental surveillance for SARS-CoV-2: Evidence from pilot sites in Blantyre, Malawi and Kathmandu, NepalLucky G Ngwira, Bhawana Sharma, Kabita Bade Shrestha, et al.
Global Health, Science and Practice|December 28, 2020
Health Care Worker Preferences and Perspectives on Doses per Container for 2 Lyophilized Vaccines in Senegal, Vietnam, and ZambiaNatasha Kanagat, Kirstin Krudwig, Karen A Wilkins, et al.
Vaccine|April 29, 2015
Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experienceBarbara Jauregui, Ana Gabriela Felix Garcia, Cara Bess Janusz, et al.
Frontiers in Public Health|March 21, 2022
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining ChallengesMateusz Hasso-Agopsowicz, Natasha Crowcroft, Robin Biellik, et al.
Vaccine|April 8, 2026
Economic evaluation of combination vaccines: Enabling a more comprehensive assessment of their benefits and challengesFrédéric Debellut, Dagna Constenla, Mercy Mvundura, et al.
Vaccine|May 13, 2014
The benefits of redesigning Benin's vaccine supply chainShawn T Brown, Benjamin Schreiber, Brigid E Cakouros, et al.
Pageof 7